Pancreatic Cancer
Pancreatic cancer refers to the carcinoma arising from the pancreatic duct cells, pancreatic ductal carcinoma, and is the fourth leading cause of cancer deaths in the United States.
Pancreatic cancer is an aggressive malignancy with a 5‑year survival rate of only 5–15%. The disease is often diagnosed at an advanced stage, limiting curative options to surgical resection in ~20% of patients. Multimodal therapy—including surgery, chemotherapy such as gemcitabine or FOLFIRINOX, and radiation—is used for locally advanced disease, while palliative measures address symptom control.
The high mortality and low 5‑year survival rate of pancreatic cancer underscore the need for improved early detection, effective therapeutic strategies, and coordinated care to enhance patient outcomes.
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.